Cno Financial Intrinsic Stock Value – CNO FINANCIAL Reports Fourth Quarter FY2022 Financial Results on December 31, 2022

Earnings Overview

CNO ($NYSE:CNO): The reported total revenue was USD 43.4 million, showing a decrease of 62.5% from the corresponding quarter of the prior fiscal year. Further, net income decreased by 9.4% year over year to USD 973.6 million.

Transcripts Simplified

CNO Financial enhanced its Medicare product offerings and capabilities with new Medicare Supplement Plan and more Medicare Advantage offerings on myHealthPolicy.com. CNO also launched Optavise, a unified worksite brand, and returned $245 million to shareholders in the year. Life and health sales were up 3% for the quarter and direct-to-consumer life sales were up 9% for the quarter and 10% for the year.

Supplemental health sales were up 26% for the quarter. Medicare Advantage policies were down 1% for the quarter, but up 6% for the year.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Cno Financial. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Cno Financial. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Cno Financial. More…

Key Ratios Snapshot

Some of the financial key ratios for Cno Financial are shown below. More…

Share Price

On Tuesday, CNO FINANCIAL announced its fourth quarter financial results for FY2022. The stock opened at $24.9 and closed at $25.4, up by 0.8% from the previous closing price of $25.2. This was the company’s first quarterly report since February of this year and showed promising figures. This sets them up for a successful FY2023, especially when taking into account their healthy cash flow. Live Quote…

Analysis – Cno Financial Intrinsic Stock Value

We at GoodWhale have conducted an analysis of CNO FINANCIAL‘s wellbeing. Using our proprietary Valuation Line, we have determined that the fair value of CNO FINANCIAL share is around $22.6. At the current time, CNO FINANCIAL stock is trading at $25.4, making it a fair price that is overvalued by 12.2%. More…

Peers

Its competitors are National Western Life Group Inc, Wustenrot & Wurttembergische AG, and iA Financial Corp Inc.

– National Western Life Group Inc ($NASDAQ:NWLI)

National Western Life Group Inc is a holding company that operates through its subsidiaries engaged in the life insurance business. Its products include whole life, term life, universal life, and annuities. The company was founded in 1906 and is headquartered in Austin, Texas.

– Wustenrot & Wurttembergische AG ($LTS:0GJN)

Wustenrot & Wurttembergische AG is a German mutual insurance company headquartered in Stuttgart. As of 2022, it had a market capitalization of €1.44 billion and a return on equity of 14.21%. The company provides a range of insurance products, including life, health, property and casualty, and pension products, as well as banking and investment products.

– iA Financial Corp Inc ($TSX:IAG)

AmeriA Financial Corp Inc has a market cap of 7.68B as of 2022. The company has a Return on Equity of 9.41%. AmeriA Financial Corp Inc is a provider of insurance and financial services. The company offers a range of products and services, including life insurance, annuities, and investments.

Summary

CNO Financial Group, Inc. has released its financial results for the fourth quarter of FY2022. Revenue saw a decrease of 62.5%, totaling to USD 43.4 million. Net income was USD 973.6 million, down 9.4% year over year. For investors, this decrease in profitability is cause for concern.

The company’s cash flow, liquidity, and capital position need to be closely monitored to assess the potential risk associated with investing in CNO Financial. Investors should continue researching potential opportunities offered by the company, as well as analyzing their financial performance over time to determine whether investing in CNO Financial is a wise decision.